NO20042273L - Polymerblandinger med kontrollert frigjoring av benvekstfremmende forbindelser - Google Patents

Polymerblandinger med kontrollert frigjoring av benvekstfremmende forbindelser

Info

Publication number
NO20042273L
NO20042273L NO20042273A NO20042273A NO20042273L NO 20042273 L NO20042273 L NO 20042273L NO 20042273 A NO20042273 A NO 20042273A NO 20042273 A NO20042273 A NO 20042273A NO 20042273 L NO20042273 L NO 20042273L
Authority
NO
Norway
Prior art keywords
controlled release
bone growth
growth promoting
polymer blends
promoting compounds
Prior art date
Application number
NO20042273A
Other languages
English (en)
Norwegian (no)
Inventor
Francis Dumont
Richard Wilker Korsmeyer
Mei Li
Vishwas Madhaw Paralkar
Richard Lee Dunn
Scott Alexander Jeffers
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20042273L publication Critical patent/NO20042273L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
NO20042273A 2001-11-30 2004-06-01 Polymerblandinger med kontrollert frigjoring av benvekstfremmende forbindelser NO20042273L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33725501P 2001-11-30 2001-11-30
PCT/IB2002/004965 WO2003045351A1 (en) 2001-11-30 2002-11-20 Controlled release polymeric compositions of bone growth promoting compounds

Publications (1)

Publication Number Publication Date
NO20042273L true NO20042273L (no) 2004-07-14

Family

ID=23319774

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042273A NO20042273L (no) 2001-11-30 2004-06-01 Polymerblandinger med kontrollert frigjoring av benvekstfremmende forbindelser

Country Status (34)

Country Link
US (2) US20030104031A1 (hr)
EP (1) EP1448166A1 (hr)
JP (1) JP4903985B2 (hr)
KR (1) KR100629380B1 (hr)
CN (1) CN1599598A (hr)
AP (1) AP1781A (hr)
AR (1) AR037462A1 (hr)
AU (2) AU2002347502A1 (hr)
BR (1) BR0214610A (hr)
CA (1) CA2468703C (hr)
DO (1) DOP2002000534A (hr)
EA (1) EA011350B1 (hr)
EC (1) ECSP045124A (hr)
GE (1) GEP20063951B (hr)
GT (1) GT200200242A (hr)
HR (1) HRP20040486A2 (hr)
HU (1) HUP0402135A3 (hr)
IL (1) IL161835A0 (hr)
IS (1) IS7217A (hr)
MA (1) MA27084A1 (hr)
MX (1) MXPA04003723A (hr)
NO (1) NO20042273L (hr)
NZ (1) NZ533115A (hr)
OA (1) OA12731A (hr)
PA (1) PA8559001A1 (hr)
PE (1) PE20030581A1 (hr)
PL (1) PL370085A1 (hr)
SV (1) SV2004001421A (hr)
TN (1) TNSN04096A1 (hr)
TW (1) TW200300695A (hr)
UA (1) UA76792C2 (hr)
WO (1) WO2003045351A1 (hr)
YU (1) YU35004A (hr)
ZA (1) ZA200402755B (hr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074425B2 (en) * 2002-09-26 2006-07-11 Bonewax, Llc Hemostatic compositions and methods
EP1596765A2 (en) * 2003-02-10 2005-11-23 Smith & Nephew, Inc. Resorbable devices
GB0307011D0 (en) 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
JP2007507516A (ja) * 2003-10-01 2007-03-29 オプティマー・ファーマスーティカルズ・インコーポレイテッド アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
GB0329654D0 (en) 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
US8641738B1 (en) 2004-10-28 2014-02-04 James W. Ogilvie Method of treating scoliosis using a biological implant
US8123787B2 (en) 2004-10-28 2012-02-28 Ogilvie James W Method of treating scoliosis using a biological implant
EP1922091A2 (en) * 2005-08-18 2008-05-21 Smith & Nephew, PLC High strength devices and composites
CN100443065C (zh) * 2006-01-26 2008-12-17 上海交通大学 用于颌面骨缺损修复的复合体系植入体单元
CN101594831B (zh) 2006-11-30 2011-09-14 史密夫和内修有限公司 纤维增强的复合材料
JP5416090B2 (ja) 2007-04-18 2014-02-12 スミス アンド ネフュー ピーエルシー 形状記憶ポリマーの膨張成形
ATE547129T1 (de) 2007-04-19 2012-03-15 Smith & Nephew Inc Multimodale formgedächtnis-polymere
US9770534B2 (en) 2007-04-19 2017-09-26 Smith & Nephew, Inc. Graft fixation
US8062739B2 (en) * 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
MX347056B (es) 2008-08-12 2017-04-10 Novartis Ag Composiciones farmaceuticas.
EP2172189A1 (en) * 2008-10-01 2010-04-07 Novartis AG Pharmaceutical Compositions
US20100130959A1 (en) * 2008-10-15 2010-05-27 Palmetto Biomedical, Inc. Device and method for delivery of therapeutic agents via artificial internal implants
US9642658B2 (en) 2008-10-15 2017-05-09 Orthoclip Llc Device and method for delivery of therapeutic agents via internal implants
CN102470184B (zh) 2009-08-06 2017-05-31 皇家飞利浦电子股份有限公司 采用放射性种子的肿瘤治疗
AU2013201121A1 (en) 2011-09-20 2013-04-04 Vical Incorporated Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
CN104189954B (zh) * 2014-09-19 2017-03-29 中国科学院长春应用化学研究所 一种原位固化组织工程支架及其制备方法
RU2571548C1 (ru) * 2014-12-17 2015-12-20 Федеральное государственное бюджетное учреждение науки Институт органической и физической химии им. А.Е. Арбузова Казанского научного центра Российской академии наук Ветеринарное имплантируемое средство пролонгированного действия (варианты)
CN108289844B (zh) 2015-11-16 2021-09-14 赢创运营有限公司 包含非核苷逆转录酶抑制剂和聚(丙交酯-共-乙交酯)的注射溶液
CN109498852B (zh) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用
EP4054591A1 (en) 2019-11-04 2022-09-14 Astrazeneca AB Combination therapy for treating cancer
KR20230150790A (ko) 2020-12-29 2023-10-31 시노 메디칼 사이언시즈 테크놀로지, 인코포레이티드 약물 용출 스텐트
WO2024089418A1 (en) 2022-10-24 2024-05-02 Cancer Research Technology Limited Tumour sensitisation to checkpoint inhibitors with redox status modifier
WO2024089417A1 (en) 2022-10-24 2024-05-02 Memorial Sloan-Kettering Cancer Center Tumour stratification for responsiveness to an immune checkpoint inhibitor
WO2024150017A1 (en) 2023-01-13 2024-07-18 Akrivia Biomedics Limited Method of profiling diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0754064B1 (en) * 1994-04-08 2003-05-28 Atrix Laboratories, Inc. An adjunctive polymer system for use with medical device
AU4652596A (en) 1995-01-09 1996-07-31 Atrix Laboratories, Inc. Liquid polymer delivery system
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
US6130200A (en) * 1996-12-20 2000-10-10 Alza Corporation Gel composition and methods
UA67754C2 (uk) * 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst

Also Published As

Publication number Publication date
PE20030581A1 (es) 2003-07-08
HRP20040486A2 (en) 2004-10-31
CN1599598A (zh) 2005-03-23
JP2005515190A (ja) 2005-05-26
AU2009200125B2 (en) 2012-02-02
ZA200402755B (en) 2005-04-08
MXPA04003723A (es) 2005-04-08
NZ533115A (en) 2005-12-23
JP4903985B2 (ja) 2012-03-28
YU35004A (sh) 2006-08-17
EA011350B1 (ru) 2009-02-27
IS7217A (is) 2004-04-07
TNSN04096A1 (fr) 2006-06-01
AU2009200125A1 (en) 2009-02-05
GEP20063951B (en) 2006-10-25
AU2002347502A1 (en) 2003-06-10
MA27084A1 (fr) 2004-12-20
CA2468703C (en) 2009-12-29
OA12731A (en) 2006-06-28
TW200300695A (en) 2003-06-16
KR20040062977A (ko) 2004-07-09
AP1781A (en) 2007-09-27
GT200200242A (es) 2003-06-25
PA8559001A1 (es) 2003-11-12
BR0214610A (pt) 2004-09-14
WO2003045351A1 (en) 2003-06-05
SV2004001421A (es) 2004-05-07
EA200400608A1 (ru) 2004-10-28
DOP2002000534A (es) 2003-05-31
US8017144B2 (en) 2011-09-13
HUP0402135A2 (hu) 2005-02-28
IL161835A0 (en) 2005-11-20
UA76792C2 (uk) 2006-09-15
AR037462A1 (es) 2004-11-10
AP2004003037A0 (en) 2004-06-30
PL370085A1 (en) 2005-05-16
ECSP045124A (es) 2004-07-23
CA2468703A1 (en) 2003-06-05
HUP0402135A3 (en) 2008-04-28
US20030104031A1 (en) 2003-06-05
US20090169595A1 (en) 2009-07-02
EP1448166A1 (en) 2004-08-25
KR100629380B1 (ko) 2006-09-29

Similar Documents

Publication Publication Date Title
NO20042273L (no) Polymerblandinger med kontrollert frigjoring av benvekstfremmende forbindelser
DE60214477D1 (de) Implantat zur Regeneration von Knorpelgewebe
FI20020772A0 (fi) Kirurginen implantti
DE50311775D1 (de) Implantat zur dynamischen fixation einer korrekturosteotomie
NO20030603D0 (no) Behandling av hyperprolifererende sykdommer med epidermale, vekstfaktorreseptorantagonister
DE60211740D1 (de) Zusammensetzung zur saatgutbehandlung
DE60215098D1 (de) Absorbierbares Gewebeimplantat
DE60322451D1 (de) 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung
FR2865377B1 (fr) Materiel d'osteosynthese vertebrale
DK1639953T3 (da) Endomedullært söm til behandling af proximale femurfrakturer
FR2856578B1 (fr) Materiel d'osteosynthese vertebrale
FR2871367B1 (fr) Implant expansible prothetique osseux
FR2859376B1 (fr) Implant rachidien
FR2863861B1 (fr) Instrument chirurgical de type declipseuse pour implant rachidien.
NO20042140L (no) Terapeutiske quionolonforbindelser med 5-HT anatagonistiske egenskaper
DE02752175T1 (de) Chirurgische Knochenreibahle
FR2846545B1 (fr) Implant d'osteosynthese intramedullaire
FR2852392B1 (fr) Composition de fixation tissulaire
AR027907A1 (es) Composicion de liberacion controlada
DE60103889D1 (de) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidderivate zur schmerzbekämpfung
FR2861981B1 (fr) Materiel d'osteosynthese vertebrale
AU2002351277A8 (en) Biodegradable, porous structures useful for growing living tissue, and methods of manufacture
DE10158785B8 (de) Medizinisches Implantat
DE50208899D1 (de) Knochenimplantat
NO20043113L (no) Fremgangsmate for behandling av benforstyrrelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application